Table of Content


Chapter 1. Global Hospital Acquired Disease Testing Market Executive Summary
1.1. Global Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
?1.3.1. By Test
?1.3.2. By Infection
?1.3.3. By Product
?1.3.4. By Type
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusion
Chapter 2. Global Hospital Acquired Disease Testing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
?2.3.1. Inclusion & Exclusion
?2.3.2. Limitations
?2.3.3. Supply-Side Analysis
??2.3.3.1. Infrastructure & Capacity
??2.3.3.2. Regulatory Environment
??2.3.3.3. Market Competition
??2.3.3.4. Economic Viability (Provider’s Perspective)
?2.3.4. Demand-Side Analysis
??2.3.4.1. HAI Prevalence & Clinical Burden
??2.3.4.2. Technological Adoption Trends
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Hospital Acquired Disease Testing Market Dynamics
3.1. Market Drivers
?3.1.1. Escalating Burden of Healthcare-Associated Infections
?3.1.2. Shift Toward Molecular and Automated Diagnostics
?3.1.3. Regulatory Mandates & Antimicrobial Stewardship Initiatives
3.2. Market Challenges
?3.2.1. High Capital and Operational Costs of Advanced Systems
?3.2.2. Skilled Personnel Shortages and Fragmented Workflows
?3.2.3. Limited Adoption in Resource-Constrained Settings
3.3. Market Opportunities
?3.3.1. Integration of AI-Enabled, Real-Time Diagnostic Platforms
?3.3.2. Decentralized Point-of-Care Testing Models
?3.3.3. Expansion of Infection Testing in AMR Surveillance Programs
Chapter 4. Global Hospital Acquired Disease Testing Market Industry Analysis
4.1. Porter’s Five Forces
?4.1.1. Bargaining Power of Suppliers
?4.1.2. Bargaining Power of Buyers
?4.1.3. Threat of New Entrants
?4.1.4. Threat of Substitutes
?4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
?4.2.1. Political
?4.2.2. Economic
?4.2.3. Social
?4.2.4. Technological
?4.2.5. Environmental
?4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Winning Market Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendations & Conclusion
Chapter 5. Global Hospital Acquired Disease Testing Market Size & Forecasts by Test (2022–2032)
5.1. Segment Dashboard
5.2. Molecular Testing Revenue Trend Analysis, 2022 & 2032
5.3. Conventional Testing Revenue Trend Analysis, 2022 & 2032
Chapter 6. Global Hospital Acquired Disease Testing Market Size & Forecasts by Infection (2022–2032)
6.1. Segment Dashboard
6.2. Urinary Tract Infection (UTI) Testing, 2022 & 2032
6.3. Pneumonia Testing, 2022 & 2032
Chapter 7. Global Hospital Acquired Disease Testing Market Size & Forecasts by Product (2022–2032)
7.1. Segment Dashboard
7.2. Instruments, 2022 & 2032
7.3. Reagents & Kits, 2022 & 2032
7.4. Software & Services, 2022 & 2032
Chapter 8. Global Hospital Acquired Disease Testing Market Size & Forecasts by Type (2022–2032)
8.1. Segment Dashboard
8.2. Automated Systems, 2022 & 2032
8.3. Manual Systems, 2022 & 2032
Chapter 9. Global Hospital Acquired Disease Testing Market Size & Forecasts by Region (2022–2032)
9.1. North America Market
?9.1.1. U.S. Market
?9.1.2. Canada Market
9.2. Europe Market
?9.2.1. UK Market
?9.2.2. Germany Market
?9.2.3. France Market
?9.2.4. Spain Market
?9.2.5. Italy Market
?9.2.6. Rest of Europe Market
9.3. Asia Pacific Market
?9.3.1. China Market
?9.3.2. India Market
?9.3.3. Japan Market
?9.3.4. Australia Market
?9.3.5. South Korea Market
?9.3.6. Rest of Asia Pacific Market
9.4. Latin America Market
?9.4.1. Brazil Market
?9.4.2. Mexico Market
?9.4.3. Rest of Latin America Market
9.5. Middle East & Africa Market
?9.5.1. Saudi Arabia Market
?9.5.2. South Africa Market
?9.5.3. Rest of Middle East & Africa Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
?10.1.1. Abbott Laboratories
?10.1.2. Thermo Fisher Scientific Inc.
?10.1.3. Becton, Dickinson and Company
10.2. Top Market Strategies
10.3. Company Profiles
?10.3.1. Abbott Laboratories
??10.3.1.1. Key Information
??10.3.1.2. Overview
??10.3.1.3. Financial (Subject to Data Availability)
??10.3.1.4. Product Summary
??10.3.1.5. Market Strategies
?10.3.2. Thermo Fisher Scientific Inc.
?10.3.3. Becton, Dickinson and Company
?10.3.4. bioM?rieux SA
?10.3.5. F. Hoffmann-La Roche Ltd.
?10.3.6. Siemens Healthineers AG
?10.3.7. Danaher Corporation
?10.3.8. Qiagen N.V.
?10.3.9. Hologic, Inc.
?10.3.10. Bio-Rad Laboratories, Inc.
?10.3.11. Cardinal Health, Inc.
?10.3.12. Cepheid (A Danaher Company)
?10.3.13. GenMark Diagnostics, Inc.
?10.3.14. QuidelOrtho Corporation
?10.3.15. Meridian Bioscience, Inc.
Chapter 11. Research Process
11.1. Data Mining
11.2. Analysis
11.3. Market Estimation
11.4. Validation
11.5. Publishing
11.6. Research Attributes



List of Figures

List of Figures
FIG 1. Research Methodology Flowchart
FIG 2. Market Estimation Techniques
FIG 3. Global Market Size: Historical vs. Forecast
FIG 4. Key Trends Influencing the Market
FIG 5. CAGR Outlook by Segment (2024–2032)
FIG 6. Porter’s Five Forces Analysis
FIG 7. PESTEL Analysis Summary
FIG 8. Value Chain Analysis
FIG 9. Market Share by Test Type (2023)
FIG 10. Market Share by Infection (2023)
FIG 11. Market Share by Product Category (2023)
FIG 12. Market Share by System Type (2023)
FIG 13. Regional Snapshot: 2022 vs. 2032
FIG 14. North America Market Trend (2022–2032)
FIG 15. Europe Market Trend (2022–2032)
FIG 16. Asia Pacific Market Trend (2022–2032)
FIG 17. Latin America Market Trend (2022–2032)
FIG 18. Middle East & Africa Market Trend (2022–2032)
FIG 19. Competitive Positioning Map
FIG 20. Forecasted Impact of AMR Initiatives on Market Growth

List of Tables

List of Tables
TABLE 1. Global Hospital Acquired Disease Testing Market, Report Scope
TABLE 2. Global Market Estimates & Forecasts by Region (2022–2032)
TABLE 3. Global Market Estimates & Forecasts by Test (2022–2032)
TABLE 4. Global Market Estimates & Forecasts by Infection (2022–2032)
TABLE 5. Global Market Estimates & Forecasts by Product (2022–2032)
TABLE 6. Global Market Estimates & Forecasts by Type (2022–2032)
TABLE 7. Global Market by Segment Combination, 2022 & 2032
TABLE 8. North America Market Estimates & Forecasts, 2022–2032
TABLE 9. U.S. Market Estimates & Forecasts by Segment, 2022–2032
TABLE 10. Canada Market Estimates & Forecasts by Segment, 2022–2032
TABLE 11. Europe Market Estimates & Forecasts, 2022–2032
TABLE 12. Asia Pacific Market Estimates & Forecasts, 2022–2032
TABLE 13. Latin America Market Estimates & Forecasts, 2022–2032
TABLE 14. Middle East & Africa Market Estimates & Forecasts, 2022–2032
TABLE 15. Competitive Landscape: Market Shares of Top 10 Companies (2023)
TABLE 16. R&D Spending of Leading Players (2022)
TABLE 17. Adoption Rates of Molecular vs. Conventional Tests (2023)
TABLE 18. Hospital HAI Incidence Rates by Region (2022)
TABLE 19. Average Test Turnaround Times by Technology (2023)
TABLE 20. Correlation of HAI Testing with AMR Reduction Outcomes